Global Artesunate Tablet Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Artesunate Tablet Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Artesunate (AS) is a medication used to treat malaria. The intravenous form is preferred to quinidine for severe malaria. Often it is used as part of combination therapy. It is not used for the prevention of malaria.
Artesunate Tablet report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Artesunate Tablet market is projected to reach US$ 240.2 million in 2034, increasing from US$ 159 million in 2022, with the CAGR of 6.0% during the period of 2024 to 2034. Demand from Hospital and Clinic are the major drivers for the industry.
Global Artesunate Tablet main players include Fosun Pharma (Guilin), Ipca Laboratories, Sanofi Aventis, Ajanta Pharma, Shin Poong, Cipla, Acino, MCW Healthcare, etc., totally accounting for about 70%. Central and South America is the largest market, with a share over 75%. As for the types of products, it can be divided into PA 90 Content, PA 95 Content and PA 98 Content. The most common product is Monoaromatic Artesunate and Compound Artesunate. In terms of applications, it is widely used in Hospital, Clinic and Others. The most application is in Hospital, with a share over 67%.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Artesunate Tablet market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
Fosun Pharma (Guilin)
Ipca Laboratories
Sanofi Aventis
Ajanta Pharma
Shin Poong
Cipla
Acino
MCW Healthcare
Segment by Type
Monoaromatic Artesunate
Compound Artesunate
Hospital
Clinic
Others
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Artesunate Tablet market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Artesunate Tablet, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Artesunate Tablet industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Artesunate Tablet in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Artesunate Tablet introduction, etc. Artesunate Tablet Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13QYResearch’s Conclusions of Artesunate Tablet market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by QYResearch.
Artesunate Tablet report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Artesunate Tablet market is projected to reach US$ 240.2 million in 2034, increasing from US$ 159 million in 2022, with the CAGR of 6.0% during the period of 2024 to 2034. Demand from Hospital and Clinic are the major drivers for the industry.
Global Artesunate Tablet main players include Fosun Pharma (Guilin), Ipca Laboratories, Sanofi Aventis, Ajanta Pharma, Shin Poong, Cipla, Acino, MCW Healthcare, etc., totally accounting for about 70%. Central and South America is the largest market, with a share over 75%. As for the types of products, it can be divided into PA 90 Content, PA 95 Content and PA 98 Content. The most common product is Monoaromatic Artesunate and Compound Artesunate. In terms of applications, it is widely used in Hospital, Clinic and Others. The most application is in Hospital, with a share over 67%.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Artesunate Tablet market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
By Company
Fosun Pharma (Guilin)
Ipca Laboratories
Sanofi Aventis
Ajanta Pharma
Shin Poong
Cipla
Acino
MCW Healthcare
Segment by Type
Monoaromatic Artesunate
Compound Artesunate
Segment by Application
Hospital
Clinic
Others
Segment by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Artesunate Tablet market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Artesunate Tablet, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Artesunate Tablet industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Artesunate Tablet in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Artesunate Tablet introduction, etc. Artesunate Tablet Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13QYResearch’s Conclusions of Artesunate Tablet market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by QYResearch.